PAPER Barrier L, Fauconneau B, Noël A, Ingrand S
SEARCH RESULTS
329938 RESULTS
PAPER Blom ES, Wang Y, Skoglund L, Hansson AC, Ubaldi M, Lourdusamy A, Sommer WH, Mielke M, Hyman BT, Heilig M, Lannfelt L, Nilsson LN, Ingelsson M
Increased mRNA Levels of TCF7L2 and MYC of the Wnt Pathway in Tg-ArcSwe Mice and Alzheimer's Disease Brain.
Int J Alzheimers Dis. 2010;2011:936580. PubMed: 21234373PAPER Suzuki T, Murakami K, Izuo N, Kume T, Akaike A, Nagata T, Nishizaki T, Tomiyama T, Takuma H, Mori H, Irie K
E22Δ Mutation in Amyloid β-Protein Promotes β-Sheet Transformation, Radical Production, and Synaptotoxicity, But Not Neurotoxicity.
Int J Alzheimers Dis. 2010 Dec 19;2011:431320. PubMed: 21234376PAPER Takeda A
Insight into glutamate excitotoxicity from synaptic zinc homeostasis.
Int J Alzheimers Dis. 2010;2011:491597. PubMed: 21234391PAPER Squitti R, Salustri C, Siotto M, Ventriglia M, Vernieri F, Lupoi D, Cassetta E, Rossini PM
Ceruloplasmin/Transferrin ratio changes in Alzheimer's disease.
Int J Alzheimers Dis. 2010;2011:231595. PubMed: 21234401PAPER Rushworth JV, Hooper NM
Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes.
Int J Alzheimers Dis. 2010;2011:603052. PubMed: 21234417PAPER Haley GE, Berteau-Pavy F, Berteau-Pavy D, Raber J
Novel image-novel location object recognition task sensitive to age-related cognitive decline in nondemented elderly.
Age (Dordr). 2012 Feb;34(1):1-10. PubMed: 21234692PAPER Bano D, Agostini M, Melino G, Nicotera P
Ageing, neuronal connectivity and brain disorders: an unsolved ripple effect.
Mol Neurobiol. 2011 Apr;43(2):124-30. PubMed: 21234815PAPER Wakasaya Y, Kawarabayashi T, Watanabe M, Yamamoto-Watanabe Y, Takamura A, Kurata T, Murakami T, Abe K, Yamada K, Wakabayashi K, Sasaki A, Westaway D, Hyslop PS, Matsubara E, Shoji M
Factors responsible for neurofibrillary tangles and neuronal cell losses in tauopathy.
J Neurosci Res. 2011 Jan 13; PubMed: 21234891PAPER Du YF, Yan P, Guo SG, Qu CQ
Effects of fibrillar Aβ(1-40) on the viability of primary cultures of cholinergic neurons and the expression of insulin signaling-related proteins.
Anat Rec (Hoboken). 2011 Feb;294(2):287-94. PubMed: 21235004PAPER Manthorpe J, Iliffe S
Viewpoint. Alzheimer's drugs debate.
Ment Health Today. 2010 Dec-2011 Jan;:31. PubMed: 21235054PAPER Trachtenberg AJ, Filippini N, Cheeseman J, Duff EP, Neville MJ, Ebmeier KP, Karpe F, Mackay CE
The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease.
Neurobiol Aging. 2012 Mar;33(3):618.e1-618.e13. PubMed: 21232817PAPER Vardy ER, Brown K, Stopford CL, Thompson JC, Richardson AM, Neary D, Kalsheker N, Morgan K, Mann DM, Snowden JS
Cognitive phenotypes in Alzheimer's disease and genetic variants in ACE and IDE.
Neurobiol Aging. 2011 Jan 11; PubMed: 21232820PAPER Mutlu NB, Değim Z, Yilmaz Ş, Eşsiz D, Nacar A
New perspective for the treatment of Alzheimer diseases: liposomal rivastigmine formulations.
Drug Dev Ind Pharm. 2011 Jul;37(7):775-89. PubMed: 21231901PAPER Casarejos MJ, Solano RM, Gómez A, Perucho J, de Yébenes JG, Mena MA
The accumulation of neurotoxic proteins, induced by proteasome inhibition, is reverted by trehalose, an enhancer of autophagy, in human neuroblastoma cells.
Neurochem Int. 2011 Mar;58(4):512-20. PubMed: 21232572Current Filters
No filters selected